DC Gets Dirty: Inside the Grimy, Body-Horror Box Office Debut of James Watkins’ Clayface

October 23, 2026 — Just in time for Halloween, the DC Universe is taking a sharp, unsettling detour into the macabre. Clayface, the much-anticipated R-rated body-horror feature directed by James Watkins, officially slithered into theaters today. Bringing one of Batman’s most tragic and grotesque rogues to the live-action big screen, the film features a haunting central performance by Tom Rhys Harries beneath layers of shifting, ruined skin.

Marking a stark tonal departure from DC Studios’ summer tentpole Supergirl, Clayface introduces audiences to a grimy, atmospheric, and deeply uncomfortable corner of Gotham City. Helmed by co-CEOs James Gunn and Peter Safran, the project represents a calculated gamble for the nascent DCU: trading four-quadrant superhero bombast for gritty, genre-specific chills, all while carrying a remarkably lean budget that changes the math on what a comic book adaptation can achieve.

'Clayface' Officially Opens With Less Than 45% of 'Supergirl's Box Office Preview Haul

Main Facts: A New Breed of DC Villain Adaptation

Co-written by modern horror auteur Mike Flanagan and Hossein Amini, Clayface follows the tragic trajectory of Matt Hagen (Tom Rhys Harries), a once-promising actor desperate to restore his severely disfigured face. However, his pursuit of a miraculous cosmetic solution goes horribly awry, trapping him inside an unstable, shapeshifting, and increasingly monstrous physiology.

Rather than leaning into standard superhero blockbuster tropes, Watkins and his creative team lean heavily into visceral, R-rated body horror. The film has already drawn critical praise for balancing its stomach-churning special effects with a deeply human core of desperation and tragedy. Furthermore, the film benefits from strong on-screen chemistry between Harries and Naomi Ackie, who portrays Dr. Caitlyn Corr—a medical professional whose dangerous, evolving relationship with Hagen anchors the narrative’s emotional stakes.

Release Date: October 23, 2026
Runtime: 108 Minutes
Director: James Watkins
Writers: Mike Flanagan and Hossein Amini
Producers: James Gunn, Lynn Harris, Matt Reeves, and Peter Safran
Distributor: Warner Bros. Pictures

Chronology: From Concept to Halloween Release

The journey of bringing Clayface to the silver screen has been closely watched by cinephiles and comic book fans alike, particularly due to the creative pedigree involved.

The Development Phase: When James Gunn and Peter Safran took the reins of DC Studios, they signaled an openness to diverse storytelling styles, including standalone genre pieces focusing on specific rogues gallery members. Mike Flanagan’s involvement lent instant credibility to the project, positioning it not as a standard superhero movie, but as a legitimate horror film set within the expansive lore of Gotham City.
The Production Cycle: Filming focused heavily on practical effects alongside cutting-edge visual enhancements to bring Hagen’s horrifying transformations to life. Tom Rhys Harries underwent grueling physical and prosthetic preparation to portray the melting, malleable antagonist.
The Fall Festival & Preview Cycle: Leading up to its October release, promotional material heavily emphasized the film’s R-rated, atmospheric horror elements. The strategy culminated in Thursday preview screenings across North America, setting the stage for an intense opening weekend showdown at the box office.

Supporting Data: Box Office Numbers and Critical Reception

While initial box office comparisons will inevitably be drawn against earlier DCU entries, industry analysts emphasize that Clayface is playing an entirely different financial game.

Opening Night and Box Office Projections

Thursday Previews: Clayface grossed an estimated $3.5 million or more during its Thursday preview night.
Comparison to Supergirl: This figure sits roughly $4.3 million behind the preview haul of Supergirl, which pulled in $7.8 million earlier in the year. However, industry experts note crucial context: Supergirl’s totals included special Wednesday fan screenings alongside its Thursday rollout. Furthermore, Clayface is a niche, R-rated horror feature opening just over a week before Halloween, targeting a distinctly different demographic.
Opening Weekend Forecasts: Domestic trackers currently place Clayface’s initial three-day weekend haul between $20 million and $25 million.

Budgetary Advantage

The most significant disparity between the two DCU releases lies in their financial risk profiles:

Supergirl Budget: Reported production budget of approximately $170 million (excluding global marketing costs).
Clayface Budget: Reported production budget of a modest $44 million (before marketing).

This staggering $126 million difference in production cost means Clayface faces a significantly lower financial hurdle to clear in order to achieve profitability. Even a modest domestic opening weekend will put the horror-centric feature on a fast track to success.

Critical Reception

While box office returns will solidify over the weekend, Clayface has already won the battle of critical acclaim. The film enters theaters bearing a 75% Certified Fresh score on Rotten Tomatoes. This stands notably higher than Supergirl, which pulled in a 52% critical approval rating, proving that audiences and critics alike are willing to embrace DC’s darker, riskier artistic ventures.

Official Responses and Creative Vision

The pivot toward low-budget, high-concept genre films within the DCU has been a cornerstone of the Gunn-Safran era. By inviting acclaimed filmmakers like James Watkins, Matt Reeves (serving as producer), and Mike Flanagan to interpret iconic properties through distinct lenses, DC Studios is deliberately courting audiences outside the traditional comic-book faithful.

In early press rounds, the filmmakers emphasized that Clayface was never intended to be a CGI-heavy superhero slugfest. Instead, it was conceptualized as a classic tragedy dressed in the skin of modern body horror. The choice to cast Tom Rhys Harries—known for his ability to convey immense vulnerability—ensures that viewers empathize with Matt Hagen even as his physical form degrades into a nightmare of mud, clay, and bone.

Naomi Ackie’s role as Dr. Caitlyn Corr has also been heavily highlighted in official production notes. Rather than serving as a standard damsel or generic scientist, Corr acts as a narrative mirror to Hagen’s descent, grounding the supernatural and horrific elements in a tense, interpersonal psychological thriller.

Implications: What Clayface Means for the Future of the DCU

The box office performance and cultural footprint of Clayface carry immense weight for the trajectory of James Gunn and Peter Safran’s shared cinematic universe.

Proof of Concept for R-Rated Genre Expansions: If Clayface successfully turns a profit on its $44 million budget, it will validate DC Studios’ strategy to greenlight mid-budget, character-driven genre films. It proves that the studio does not need to spend $150 million+ on every single property to capture public interest.
Capitalizing on the Halloween Window: Releasing a gritty, atmospheric horror film in late October is a classic theatrical strategy that has historically benefited horror mainstays. If horror fans turn out en masse to support Clayface over the weekend, it could establish a profitable blueprint for alternative seasonal releases in the superhero genre.
Diversifying the Brand: For years, comic book cinematic universes have struggled with franchise fatigue, often attributed to formulaic three-act structures and interchangeable visual styles. By handing the keys of a major Batman rogue over to horror directors and letting them craft an R-rated body-horror drama, DC is actively reshaping audience expectations.

As the weekend progresses and updated box office figures roll in, all eyes will be on Gotham’s newest, muddiest monster to see if he can carry his own weight at the box office—and whether DC’s dark gamble pays off. Clayface is playing in theaters everywhere now.